C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy

Clinical trial NCT07729826 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07729826
Sponsor: AbelZeta Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis (LN)Systemic Lupus Erythematosus (SLE)

Start date: 2026-09-30
Primary completion: 2028-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.